Benjamin Edwards’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
Benjamin Edwards's BEAM Position: Q3 2026 in Review
Benjamin Edwards increased its Beam Therapeutics (BEAM) stake by 7% in Q3 2026, buying an estimated $60.2K and bringing the position to 33,172 shares worth $811K. The position accounts for 0.01% of the portfolio, ranked #882.
Benjamin Edwards first reported a position in BEAM in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.06M in Q2 2026. 191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Benjamin Edwards held 33,172 shares of Beam Therapeutics worth $811K as of Q3 2026.
- Benjamin Edwards bought 2,163 Beam Therapeutics shares in Q3 2026, an estimated $60.2K.
- Beam Therapeutics made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #882 holding.
- Benjamin Edwards first reported a position in Beam Therapeutics in Q4 2022 and has held it in 16 quarters since.
- Benjamin Edwards's Beam Therapeutics position peaked at $1.06M in Q2 2026.
- 191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.